Related Experiment Video

Updated: Sep 27, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

Cellular and molecular aspects of drugs of the future: meropenem

P Cottagnoud1

  • 1Department of Internal Medicine, Inselspital Bern, Bern, Switzerland. pcottagn@insel.ch

Cellular and Molecular Life Sciences : CMLS
|January 18, 2003
PubMed

Insights

Meropenem is a crucial carbapenem antibiotic effective against severe infections. It overcomes common bacterial resistance mechanisms and offers a favorable safety profile, unlike imipenem.

Area of Science:

  • Pharmacology
  • Microbiology
  • Infectious Diseases

Background:

  • Meropenem is a key beta-lactam antibiotic from the carbapenem subclass.
  • It is vital for treating severe, life-threatening bacterial infections.
  • Its chemical structure confers stability against kidney dehydropeptidase I and most beta-lactamases.

Purpose of the Study:

  • To review the properties, mechanism of action, and resistance patterns of meropenem.
  • To highlight its clinical significance in combating resistant bacterial infections.
  • To compare its safety profile with other carbapenems like imipenem.

Main Methods:

  • Review of existing literature on meropenem's synthesis and properties.
  • Analysis of meropenem's interaction with bacterial targets (penicillin-binding proteins).
  • Examination of documented bacterial resistance mechanisms against carbapenems.

Main Results:

  • Meropenem exhibits broad-spectrum activity against Gram-positive and Gram-negative bacteria.
  • Key resistance mechanisms include altered penicillin-binding proteins, reduced permeability, efflux pumps, and carbapenemases.
  • Meropenem demonstrates a low toxicity profile, notably lacking the central nervous system toxicity associated with imipenem.

Conclusions:

  • Meropenem remains a critical therapeutic option for serious infections due to its efficacy and stability.
  • Understanding bacterial resistance is essential for optimizing meropenem's clinical use.
  • Its favorable safety profile makes it a preferred choice in many clinical settings.

More Related Videos

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Cellular Membranes and Drug Transport01:24

Cellular Membranes and Drug Transport

Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.